Logo 1 Logo 2

Clinical Trial Details

Trial ID: L4823
Source ID: NCT06495814
Associated Drug: 1/Bag Of Jinlida Granules, 3 Times/Day, Taken With Hot Water.
Title: Characterization and Mechanism Research of the Pre-disease State of Obese Type 2 Diabetes Mellitus
Acronym:
Status: NOT_YET_RECRUITING
Study Results: NO
Results:
Conditions: Obese Impaired Glucose Tolerance|Newly Diagnosed Obese Type 2 Diabetic Patients
Interventions: DRUG: 1/bag of Jinlida granules, 3 times/day, taken with hot water.
Outcome Measures: Primary: incidence of diabetes, During the follow-up period, when the subjects measured abnormal fasting blood glucose, venous blood was collected and OGTT was measured. Subjects who were diagnosed with type 2 diabetes according to the OGTT results and who were still diagnosed with type 2 diabetes by OGTT one week later were defined as the occurrence of diabetes., Both the observation group and the intervention group were followed up for 12 months, once a month. |
Sponsor/Collaborators: Sponsor: Fengmei Lian
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 380
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2024-07-01
Completion Date: 2026-12-30
Results First Posted:
Last Update Posted: 2024-07-11
Locations:
URL: https://clinicaltrials.gov/show/NCT06495814